US 4,376,858 A · 2-4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline salts

Abstract

2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline salts, pharmaceutical compositions containing said salts, methods of treating malaria, and bacterial infections employing said salts and compositions and methods for producing said salts.

Claims5

Dependent claims

A compound of the formula ##STR3## wherein Z is 2-hydroxyethanesulfonic acid or glucuronic acid.

Dependencies are inferred from the claim text.

Facts

Application

06/344,350Filed 29 Jan 1982 · continuation

Priority

31 Oct 1980

Granted

15 Mar 1983

Term ends

Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07D 239/95
Quinazolines; Hydrogenated quinazolines: with hetero atoms directly attached in positions 2 and 4
Y02A 50/30
In human health protection, e.g. against extreme weather: against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne…
C07D
Heterocyclic compounds
Y02A
Technologies for adaptation to climate change

2-4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline salts

Life of this patent

Abstract

Claims5

2-4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline salts

Life of this patent

Abstract

Claims5